z-logo
Premium
The treatment of a thyrotropin‐secreting pituitary macroadenoma with octreotide in twin pregnancy
Author(s) -
Blackhurst G.,
Strachan M. W.,
Collie D.,
Gregor A.,
Statham P. F. X.,
Seckl J. E. R.
Publication year - 2002
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1046/j.1365-2265.2002.01549.x
Subject(s) - octreotide , medicine , pregnancy , euthyroid , endocrinology , refractory (planetary science) , adenoma , pituitary adenoma , pituitary tumors , pituitary gland , hormone , somatostatin , biology , genetics , astrobiology
Summary TSH‐secreting pituitary tumours are rare but difficult to treat due to a combination of refractory hyperthyroidism and low surgical cure rates. We describe the case of a 21‐year‐old woman who, despite twin pregnancy, became euthyroid and had dramatic tumour shrinkage on octreotide treatment. To our knowledge, this is the first description of the use of octreotide for a TSH‐secreting pituitary adenoma throughout pregnancy.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here